Correct option is D
The correct answer is: (d) Indian Institute of Science and National Institute of Biomedical Genomics
India’s first indigenous mRNA vaccine technology against COVID-19 was developed collaboratively by the Indian Institute of Science (IISc), Bengaluru, and the National Institute of Biomedical Genomics (NIBMG), Kalyani. This vaccine platform is thermostable, cost-effective, and marks a major step in India's biotechnology and vaccine development capabilities.
mRNA vaccines work by introducing genetic instructions to produce viral proteins that trigger an immune response.
Unlike conventional vaccines, they are synthetic and quicker to produce.
India’s initiative aimed at self-reliance in vaccine technologies under Atmanirbhar Bharat.
This development is significant as most mRNA vaccines (like Pfizer-BioNTech and Moderna) were previously imported.
The Indian mRNA vaccine candidate is expected to be more affordable and easier to store in Indian settings.